The Latest Breaking News from JNJ

Pharmaceutical giant Johnson & Johnson (JNJ) topped consensus estimates in the last quarter. Shares of this well-established blue-chip company are all set to weather the possible market volatility next year. Read on….

Persistently high inflation and the Federal Reserve’s hawkish stance to handle it has resulted in significant market volatility this year. Moreover, experts amplified their warnings of a recession next year. Given the uncertain market backdrop, it could be wise to invest in fundamentally sound and resilient stocks, Johnson & Johnson…

After the Fed Chair's assurance about the eventual rate hike slowdown, the Dow gained substantially and entered a new bull market. Moreover, the U.S. economy seems resilient enough to withstand any potential growth reduction. Therefore, investors could consider buying fundamentally sound Dow stocks Johnson & Johnson (JNJ) and Cisco Systems…

Recent data indicates the signs of slowing down inflation. Additionally, the Fed is leaning toward slowing its pace of rate hikes. Amid this, fundamentally strong stocks Johnson & Johnson (JNJ), CVS Health (CVS), Douglas Dynamics (PLOW), and Genie Energy (GNE) might be ideal additions to your portfolio this winter. Continue…

The Fed’s aggressive monetary policy stance created immense recession fear until the inflation showed signs of cooling down in October, and the policymakers hinted at a slower pace of rate hikes. Amid such an uncertain macroeconomic scenario, investors could consider buying safe-haven stocks Johnson & Johnson (JNJ), The Coca-Cola Company…

The Fed might be on course to trigger market volatility with another interest rate hike next month. With an end to the Fed’s campaign on inflation through rate hikes nowhere in sight, it would be wise to invest in resilient stocks Microsoft (MSFT), Johnson & Johnson (JNJ), and Coca-Cola (KO),…

The healthcare industry is expected to witness significant growth in the foreseeable future, driven by rising health awareness, an aging population, and increasing chronic diseases worldwide. Furthermore, the healthcare industry is known to perform steadily regardless of economic conditions because of the inelastic demand for healthcare products and services. Therefore,…

Although October CPI data came in lower than expected, inflation is still hovering at an uncomfortably high level. As the Fed is expected to maintain its hawkish stance to control such high inflation, the economy could witness a recession next year. Hence, it could be wise to invest in defensive…

Leading healthcare company Johnson & Johnson (JNJ) has been able to navigate the volatile market conditions due to the defensive nature of its business and solid fundamentals. Moreover, the company has an impressive history of increasing its dividends. Given JNJ’s robust financials, high profitability, and consistent dividend payouts, we think…

Despite the October inflation report showing a slowdown in the price increases, the U.S. economy is still surrounded by deep uncertainty. Moreover, the IMF has warned of further challenges ahead. Therefore, quality stocks Johnson & Johnson (JNJ) and Coca-Cola (KO), which have a solid dividend-paying record, could be ideal additions…

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.